Shares of Alembic Pharmaceuticals edged up 1.09 percent to Rs 772.55 after the company revealed plans to strengthen its global footprint with a new subsidiary in Southeast Asia. The move signals Alembic Pharmaceuticals’ continued push into...
Amneal Pharmaceuticals has announced a major acquisition deal worth up to $1.1 billion acquisition to acquire Kashiv BioSciences, strengthening its presence in the fast-growing biosimilars market. The move reflects the increasing focus among pharm...
Indian pharmaceutical company Lupin Limited has expanded its presence in the U.S. healthcare market with the launch of a diabetes medication after receiving approval from the United States Food and Drug Administration.
In an interview on “How India Built Pharma Industry Against All Odds,” Manish Sabharwal, Co-Founder of TeamLease Services, breaks down the rise of India’s pharmaceutical sector. He explores how a constrained economy and a tightly regulated...
India’s ammonia rule is tightening the availability of a key raw material for pharmaceutical companies, after the government directed that surplus ammonia from urea plants be reserved primarily for fertilizer production.
India’s healthcare landscape is undergoing a remarkable transformation, driven by a new generation of MedTech startups focused on developing affordable, high-quality medical technologies. With increasing demand for accessible healthcare solutions
India is facing a serious thalassemia drug shortage, prompting the government to seek an explanation from Novartis while exploring generic alternatives to stabilize supply. The issue centers on Desferal, a life-saving treatment used by...
Eli Lilly is in advanced discussions to acquire Kelonia Therapeutics in a deal valued at more than $2 billion, signaling a strong push into next-generation cancer treatments.
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have entered into a strategic partnership to support the development and manufacturing of antibody-drug conjugates (ADCs), an emerging class of targeted cancer therap...
Indian pharma companies are witnessing a sharp drop in semaglutide API price even as demand for GLP-1 drugs surges across the country. The fall comes right after the patent expiry of semaglutide in India, which has opened the market to a wave of...
.jpg)
.jpg)
, CDSCO.jpg)